Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Obesity


Insulin-Stimulated Muscle Glucose Uptake and Insulin Signaling in Lean and Obese Humans

January 6th 2021

We suggest that reduced muscle glucose uptake in obesity is not due to defects in the insulin signaling pathway at the level of Akt/AS160, which suggests there remain significnt gaps in our knowledge of muscle insulin resistance in obesity. Our data imply that models of acute lipotoxicity don’t replicate the pathophysiology of obesity (Journal of Clinical Endocrinology & Metabolism)

Categories: News, Obesity
Tags: glucose uptake, insulin

Categories: Obesity
Tags: glucose uptake, insulin

Durability of glycaemic control in type 2 diabetes: A systematic review and meta‐analysis for its association with body weight changes

November 11th 2020

Modest weight loss with a goal of 2‐3% of body weight should be recommended to improve therapeutic durability and prevent beta‐cell deterioration (Diabetes, Obesity and Metabolism)

Categories: News, Obesity
Tags: glycaemic control, Type 2 Diabetes

Categories: Obesity
Tags: glycaemic control, Type 2 Diabetes

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

April 1st 2020

In adolescents with obesity, the use of liraglutide (3.0 mg) plus lifestyle therapy led to a significantly greater reduction in the BMI standard-deviation score than placebo plus lifestyle therapy (NEJM)

Categories: News, Obesity
Tags: BMI, liraglutide

Categories: Obesity
Tags: BMI, liraglutide

Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes

March 22nd 2020

A gradual increase in assessed functional β-cell capacity occurred after weight loss, becoming similar to that of NDC group participants by 12 months. This result was unchanged at 2 years with continuing remission of type 2 diabetes (Diabetes Care)

Categories: News, Obesity
Tags: bcell, Type 2 Diabetes

Categories: Obesity
Tags: bcell, Type 2 Diabetes

Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study

April 23rd 2019

Among persons with weight loss of at least 5% after 1 year, those originally randomly assigned to metformin had the greatest loss during years 6 to 15. Older age and the amount of weight initially lost were the most consistent predictors of LTWL maintenance (Annals of Internal Medicine)

Categories: News, Obesity
Tags: metformin

Categories: Obesity
Tags: metformin

Adiposity and Diabetes Risk in Adults with Prediabetes: Heterogeneity of Findings Depending on Age and Anthropometric Measure

August 7th 2018

The association of central adiposity with type 2 diabetes incidence was lower for people in the older age group than for those in the younger age group (Obesity)

Categories: News, Obesity
Tags: central adiposity, Type 2 Diabetes

Categories: Obesity
Tags: central adiposity, Type 2 Diabetes

Uptake and retention in group-based weight-management services

July 19th 2018

Literature review and behavioural analysis (Public Health England)

Categories: News, Obesity
Tags: weight management

Categories: Obesity
Tags: weight management

Childhood obesity: Time for action

May 31st 2018

Current estimates suggest that nearly a third of children aged 2 to 15 in the UK are overweight or obese. These children and young people are becoming obese at an earlier age and staying obese for longer. The personal cost for children living with a lifetime of obesity is immense and they are more than twice as likely to die prematurely as a result (Parliament, UK)

Categories: News, Obesity
Tags: childhood, overweight

Categories: Obesity
Tags: childhood, overweight

Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents

March 29th 2018

Compared with medical therapy, surgical treatment of severely obese adolescents with type 2 diabetes was associated with better glycemic control, reduced weight, and improvement of other comorbidities (JAMA Pediatrics)

Categories: News, Obesity
Tags: medical, surgical, Type 2 Diabetes

Categories: Obesity
Tags: medical, surgical, Type 2 Diabetes

Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study

January 16th 2018

In extended follow-up of obese adults with type 2 diabetes randomized to adding gastric bypass compared with lifestyle and intensive medical management alone, there remained a significantly better composite triple end point in the surgical group at 5 years. However, because the effect size diminished over 5 years, further follow-up is needed to understand the durability of the improvement (JAMA)

Categories: News, Obesity
Tags: cholesterol, HbA1c, Roux-en-Y Gastric, Type 2 Diabetes

Categories: Obesity
Tags: cholesterol, HbA1c, Roux-en-Y Gastric, Type 2 Diabetes

Body mass index and all-cause mortality among type 2 diabetes mellitus patients: Findings from the 5-year follow-up of the MADIABETES cohort

July 12th 2017

In an outpatient T2DM Mediterranean population sample, low BMI predicted all-cause mortality only in males (European Journal of Internal Medicine)

Categories: Obesity
Tags: BMI, Type 2 Diabetes

Obese, overweight with risk factors: liraglutide (Saxenda)

June 27th 2017

This evidence summary discusses 4 randomised controlled trials (RCTs) in adults who were obese or overweight (BMI 27 kg/m2 or above) with a variety of weight-related comorbidities including dyslipidaemia, hypertension, type 2 diabetes and obstructive sleep apnoea (NICE)

Categories: News, Obesity
Tags: liraglutide, NICE

Categories: Obesity
Tags: liraglutide, NICE

Health Effects of Overweight and Obesity in 195 Countries over 25 Years

June 16th 2017

The rapid increase in the prevalence and disease burden of elevated BMI highlights the need for continued focus on surveillance of BMI and identification, implementation, and evaluation of evidence-based interventions to address this problem (NEJM)

Categories: News, Obesity
Tags: BMI

Categories: Obesity
Tags: BMI

Effect of Weight Reduction on Hemoglobin A1c in weight loss trials of Type 2 Diabetes Patients

April 18th 2017

The model developed here estimates that for each kg of mean weight loss, there is a mean HbA1c reduction of 0.1 % units … this summary of data may be used to support the design and interpretation of future studies that aim to demonstrate the efficacy of weight loss interventions for T2D treatment  (Diabetes, Obesity and Metabolism)

Categories: News, Obesity
Tags: HbA1c, Type 2 Diabetes

Categories: Obesity
Tags: HbA1c, Type 2 Diabetes

Comparison of body mass index at diagnosis of diabetes in a multiethnic population

February 23rd 2017

Risk patterns of developing diabetes at different levels of obesity varies between ethnic groups across all age groups, while South Asians and African-Caribbeans carry the highest risk at younger age and at lower adiposity burden (Diabetes, Obesity and Metabolism)

Categories: News, Obesity
Tags: adiposity, multiethnic

Categories: Obesity
Tags: adiposity, multiethnic

Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity

January 10th 2017

The association of S/P with the metabolic status of obese individuals was further validated in a cross-sectional cohort of 381 participants. In summary, higher baseline S/P was associated with greater probability of diabetes remission after RYGB and may serve as a diagnostic marker in preoperative patient assessment (FASEB)

Categories: News, Obesity
Tags: Roux-en-Y

Categories: Obesity
Tags: Roux-en-Y

Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus

January 2nd 2017

In type 2 diabetes, BMI is nonlinearly associated with all-cause mortality with lowest risk in the overweight group in both men and women. Further research is needed to clarify the relationship with cardiovascular mortality and assess causality and sex differences (Diabetologia)

Categories: News, Obesity
Tags: BMI, mortality, Type 2 Diabetes

Categories: Obesity
Tags: BMI, mortality, Type 2 Diabetes

Attitudes to obesity

December 8th 2016

Findings from the 2015 British Social Attitudes survey (Public Health England)

Categories: News, Obesity
Tags: survey

Categories: Obesity
Tags: survey

BMI at Age 17 Years and Diabetes Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents

October 25th 2016

Adolescent BMI, including values within the currently accepted “normal” range, strongly predicts DM mortality up to the seventh decade (Diabetes Care)

Categories: News, Obesity
Tags: BMI, mortality

Categories: Obesity
Tags: BMI, mortality

Body Mass Index at Age 17 and Diabetes Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents

October 13th 2016

Adolescent BMI, including values within the currently accepted “normal” range, strongly predicts DM mortality up to the seventh decade. The increasing prevalence of childhood and adolescent overweight and obesity points to a substantially increased future adult DM burden (Diabetes Care)

Categories: Obesity
Tags: BMI, mortality

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

AstraZenecaNapp DiabetesNovo NordiskSanofi Diabetes

Silver Sponsors

Abbott Diabetes CareAmgenWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership